1.1B US doctor visits in 2006, 2.6B drugs Rxed

10 August 2008

US patients made an estimated 1.1 billion visits to physician offices and hospital out-patient or emergency departments in 2006, an average of four visits per person for the year, according to new health care statistics released by the Centers for Disease Control and Prevention (CDC). Seven out of 10 visits had at least one medication provided, prescribed or continued, for a total of 2.6 billion drugs overall. Analgesics were the most common, accounting for 13.6% of all drugs prescribed, and were most often used during primary care and emergency department visits.

The data, compiled from various components of CDC's National Center for Health Statistics National Health Care Survey, are featured in a series of new National Health Statistics Reports. The number of visits to physician offices and hospital out-patient and emergency departments increased by 26% from 1996 to 2006, faster than the USA's population growth (11%). This development can be linked to the aging of the population.

Patients with Medicaid use the emergency department far more frequently, the CDC noted, than those with private insurance, 82 per 100 persons for Medicaid versus 21 per 100 for private insurance.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight